Together with the added advantage that CRISPRi with dCas9-KRAB does not involve direct modification of the DNA sequence but solely epigenomic editing, we focused our further investigation on the EGFR enhancer-repressed glioblastoma cell lines. Here, EGFR is linked to glioblastoma.